QMed (QMED) Stock Price, News & Analysis

Company Overview

QMed AB, trading under the symbol QMED on the OTC Markets, is a Swedish biotechnology company specializing in the development and commercialization of hyaluronic acid–based soft tissue fillers. Its core product portfolio includes injectable formulations designed for both aesthetic enhancements and reconstructive treatments, with its flagship Restylane line addressing wrinkle correction, facial contouring and skin hydration. QMed’s proprietary cross-linking technology enables precise control of gel properties, delivering tailored solutions for various clinical applications.

Founded in 1996 and headquartered in Uppsala, Sweden, QMed grew through a combination of in-house research and strategic partnerships. The company secured CE marking in Europe and subsequently obtained U.S. Food and Drug Administration approval, paving the way for distribution across North America, Asia-Pacific and select emerging markets. QMed maintains research facilities in Sweden, where it focuses on advancing hyaluronic acid chemistry and expanding indications into areas such as body contouring and scar management.

In July 2011, QMed was acquired by Galderma, a global leader in dermatological solutions backed by Nestlé Skin Health. The acquisition integrated QMed’s product lines and R&D capabilities into Galderma’s broader portfolio, reinforcing the combined organization’s position in the medical aesthetics industry. Although QMed now operates under the Galderma umbrella, its technology and product innovations continue to underpin a range of restorative and aesthetic treatments worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/22/2026
• Fiscal Year End: 11/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:QMED
• CIK: N/A
• Web: www.qmedinc.com
• Phone: (732) 544-5544
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A